These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7429116

  • 1. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy.
    Horst DA, Grace ND, LeCompte PM.
    Gastroenterology; 1980 Sep; 79(3):550-4. PubMed ID: 7429116
    [Abstract] [Full Text] [Related]

  • 2. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
    Balan V, Batts KP, Porayko MK, Krom RA, Ludwig J, Wiesner RH.
    Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
    [Abstract] [Full Text] [Related]

  • 3. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.
    Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodés J, Tygstrup N, Williams R.
    Gastroenterology; 1980 Feb; 78(2):236-46. PubMed ID: 7350046
    [Abstract] [Full Text] [Related]

  • 4. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS, Lefkowitch J, Berk PD.
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [Abstract] [Full Text] [Related]

  • 5. Liver histology in benign biliary stricture: fibrosis to cirrhosis . . . and reversal?
    Sikora SS, Srikanth G, Agrawal V, Gupta RK, Kumar A, Saxena R, Kapoor VK.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1879-84. PubMed ID: 19120875
    [Abstract] [Full Text] [Related]

  • 6. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A, May B, Klein CG, Klein R, Fisseler-Eckhoff A, Griga T.
    Hepatogastroenterology; 2005 Dec; 52(63):753-6. PubMed ID: 15966198
    [Abstract] [Full Text] [Related]

  • 7. Screening patients with celiac disease for primary biliary cirrhosis and vice versa.
    Bardella MT, Quatrini M, Zuin M, Podda M, Cesarini L, Velio P, Bianchi P, Conte D.
    Am J Gastroenterol; 1997 Sep; 92(9):1524-6. PubMed ID: 9317077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Symptomatic primary biliary stenosis without cholestasis].
    Velicia Llames MR, González Hernández JM, Fernández Orcajo P, Sanz Santacruz C.
    Gastroenterol Hepatol; 1995 Sep; 18(6):330-1. PubMed ID: 7627824
    [Abstract] [Full Text] [Related]

  • 14. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP, Jorgensen RA, Dickson ER, Lindor KD.
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [Abstract] [Full Text] [Related]

  • 15. The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis.
    Bach N, Thung SN, Schaffner F.
    Arch Pathol Lab Med; 1998 Apr; 122(4):342-5. PubMed ID: 9648903
    [Abstract] [Full Text] [Related]

  • 16. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial.
    Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R.
    Gastroenterology; 1980 May; 78(5 Pt 1):1005-10. PubMed ID: 6991353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.